about
Modulation of CD6 function through interaction with Galectin-1 and -3Tumor-induced disruption of proximal TCR-mediated signal transduction in tumor-infiltrating CD8+ lymphocytes inactivates antitumor effector phaseTransgenic expression of soluble human CD5 enhances experimentally-induced autoimmune and anti-tumoral immune responsesThe immunomodulatory properties of the CD5 lymphocyte receptor in health and disease.CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction.Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infection.
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CD5 sweetens lymphocyte responses
@en
CD5 sweetens lymphocyte responses.
@nl
type
label
CD5 sweetens lymphocyte responses
@en
CD5 sweetens lymphocyte responses.
@nl
prefLabel
CD5 sweetens lymphocyte responses
@en
CD5 sweetens lymphocyte responses.
@nl
P2860
P356
P1476
CD5 sweetens lymphocyte responses
@en
P2093
Laurel L Lenz
P2860
P304
P356
10.1073/PNAS.0812579106
P407
P577
2009-01-27T00:00:00Z